Search

everythinglearnresearchcommunity

for

Search:↓

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Hair loss treatment caused more hair loss in a man.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.